We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Stefano Del Prato MD

Stefano Del Prato MD

Professor of Endocrinology, Section of Diabetes and Metabolic Diseases, University of Pisa, Pisa, Italy

Stefano Del Prato is Professor of Endocrinology and Metabolism at the School of Medicine, University of Pisa and Chief of the Section of Diabetes, University Hospital of Pisa, Italy. He graduated from the University of Padova, Italy and undertook postgraduate specialization in Endocrinology and Internal Medicine. He has been Associate Professor of Medicine at the University of Texas, San Antonio, TX, USA. Professor Del Prato’s main research interests have always been the physiopathology and therapy of type 2 diabetes and insulin resistance. He is a member of many societies and associations including the European Association for the Study of Diabetes (EASD) and the American Diabetes Association. He acts as referee for numerous journals and has served on the Editorial Boards of major scientific journals in the field of diabetes and metabolism. Professor Del Prato is past Vice-President of the EASD, past Chairman of the European Foundation for the Study of Diabetes (EFSD), past President and Honorary President of the Italian Society of Diabetology, and the current President of the European Association for the Study of Diabetes. He also served as Chairman of the Scientific Committee of the World Diabetes Congress in Dubai, UAE, in 2011. He has published over 500 articles in peer-reviewed international journals and has been awarded several honors including the Prize of the Italian Society of Diabetology for outstanding scientific activity, the Honorary Professorship at the Universidad Peruana Cayetano Heredya in Lima and the title of Commander of the Order of the Italian Republic.


Prof. Del Prato reports the following:
  • Advisory panels: Applied Therapeutics, AstraZeneca; Boehringer Ingelheim; Eli Lilly and Co; Merck & Co.; Menarini Pharmaceuticals; Novartis Pharmaceuticals; Novo Nordisk; Sanofi
  • Speaker bureau: AstraZeneca; Boehringer Ingelheim; Eli Lilly and Co; Merck & Co.; Novartis Pharmaceuticals; Novo Nordisk; Sanofi;
  • Research support: AstraZeneca; Boehringer Ingelheim